Hilltop National Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$147K Buy
379
+55
+17% +$20.4K 0.03% 300
2026
Q1
$94.9K Buy
324
+61
+23% +$20K 0.02% 359
2025
Q4
$92.2K Buy
+263
New +$88.9K 0.02% 352
2024
Q4
$22.1K Sell
60
-6
-9% -$2.51K 0.01% 539
2024
Q3
$34.3K Buy
66
+23
+53% +$12.3K 0.01% 516
2024
Q2
$23.3K Hold
43
0.01% 544
2024
Q1
$22.3K Buy
+43
New +$21.4K 0.01% 542

Other funds holding ELV

Hilltop National Bank's ELV Position: Q2 2026 in Review

Hilltop National Bank increased its Elevance Health (ELV) stake by 17% in Q2 2026, buying an estimated $20.4K and bringing the position to 379 shares worth $147K. The position accounts for 0.03% of the portfolio, ranked #300.

Hilltop National Bank first reported a position in ELV in Q1 2024 and has held it in 7 quarters since. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Hilltop National Bank held 379 shares of Elevance Health worth $147K as of Q2 2026.
  • Hilltop National Bank bought 55 Elevance Health shares in Q2 2026, an estimated $20.4K.
  • Elevance Health made up 0.03% of Hilltop National Bank's portfolio in Q2 2026, its #300 holding.
  • Hilltop National Bank first reported a position in Elevance Health in Q1 2024 and has held it in 7 quarters since.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.